FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster.
The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website.
By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser .
Research Articles Abstract - 2012 Issues Archive
Research Articles Abstracts ? May 26 2012 Issue
Research Articles Abstracts ? May 26 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts ? May 26 2012 Issue Abstracts List
Simeonova L, Gegova G, Galabov AS.
Prophylactic and therapeutic combination effects of rimantadine and oseltamivir against influenza virus a (H3N2) infection in mice.
Starick E, Lange E, Grund C, Grosse Beilage E, et al.
Reassortants of pandemic influenza A virus H1N1/2009 and endemic porcine HxN2 viruses emerge in swine populations in Germany.
Flynn PM, Nachman S, Muresan P, Fenton T, et al.
Safety and Immunogenicity of 2009 Pandemic H1N1 Influenza Vaccination in Perinatally HIV-1 Infected Children and Youth.
Miller AL, Sims GP, Brewah YA, Rebelatto MC, et al.
Opposing roles of membrane and soluble forms of the receptor for advanced glycation end products in primary respiratory syncytial virus infection.
Roelandt S, Outtrim L, Browning C, Alexander DJ, et al.
Evaluation of two different swab transport systems in the detection of avian influenza virus excretion from infected Pekin ducks (Anas platyrhynchos).
Noda T, Kawaoka Y.
Packaging of influenza virus genome: Robustness of selection.
Li GM, Chiu C, Wrammert J, McCausland M, et al.
Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.
Roy A, Post CB.
Long-distance correlations of rhinovirus capsid dynamics contribute to uncoating and antiviral activity.
Villenave R, Thavagnanam S, Sarlang S, Parker J, et al.
In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo.
Hatz C, Cramer JP, Vertruyen A, Schwarz TF, et al.
A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations.
Graitcer SB, Dube NL, Basurto-Davila R, Smith PF, et al.
Effects of immunizing school children with 2009 influenza A (H1N1) monovalent vaccine on absenteeism among students and teachers in Maine.
Domingues CM, de Oliveira WK.
Uptake of pandemic influenza (H1N1)-2009 vaccines in Brazil, 2010.
Ebrahimi SM, Dabaghian M, Tebianian M, Zabeh Jazi MH, et al.
In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.
Jazi MH, Dabaghian M, Tebianian M, Gharagozlou MJ, et al.
In vivo electroporation enhances immunogenicity and protection against influenza A virus challenge of an M2e-HSP70c DNA vaccine.
Pantin-Jackwood MJ, Smith DM, Wasilenko JL, Cagle C, et al.
Effect of age on the pathogenesis and innate immune responses in Pekin ducks infected with different H5N1 highly pathogenic avian influenza viruses.
Katsumi Y, Otabe O, Matsui F, Kidowaki S, et al.
Effect of a Single Inhalation of Laninamivir Octanoate in Children With Influenza.
-
------
Research Articles Abstracts?June 2 2012 Issue
Research Articles Abstracts?June 2 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?June 2 2012 Issue Abstracts List
Xie T, Liang J, Liu N, Wang Q, et al.
MicroRNA-127 inhibits lung inflammation by targeting IgG Fcgamma receptor I.
Terrier O, Marcel V, Cartet G, Lane DP, et al.
Influenza A viruses control the expression of pro-viral human p53 isoforms, p53beta and {Delta}133p53alpha
Bodewes R, Fraaij PL, Kreijtz JH, Geelhoed-Mieras MM, et al.
Annual influenza vaccination affects the development of heterosubtypic immunity.
Prematunge C, Corace K, McCarthy A, Nair R, et al.
Factors influencing pandemic influenza vaccination of healthcare workers-A systematic review.
Zhang J, While AE, Norman IJ.
Nurses' vaccination against pandemic H1N1 influenza and their knowledge and other factors.
Creskey MC, Li C, Wang J, Girard M, et al.
Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MS(E).
Middleman AB, Short MB, Doak JS.
School-located influenza immunization programs: Factors important to parents and students.
Wells G, Addington-Hall M, Malur AG.
Mutations within the human parainfluenza virus type 3C protein affect viral replication and host interferon induction.
-
-------
Research Articles Abstracts ? June 8 2012 Issue
Research Articles Abstracts ? June 8 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts ? June 8 2012 Issue Abstracts List
CHIAPPONI C, Moreno A, Barbieri I, Merenda M, et al.
Multiplex RT-PCR assay for differentiating European swine influenza virus subtypes H1N1, H1N2 and H3N2.
ARVIA R, Corcioli F, Simi L, Orlando C, et al.
Monitoring the susceptibility to oseltamivir of Influenza A(H1N1) 2009 virus by nested-PCR and pyrosequencing during the pandemic and in the season 2010-2011.
YU M, Li G, Lee WW, Yuan M, et al.
Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age.
PETOUSIS-HARRIS H, Poole T, Turner N, Reynolds G, et al.
Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: The importance of routine active safety surveillance.
RIVERA L, Mazara S, Vargas M, Fragapane E, et al.
Phase III, randomized controlled trial to evaluate lot consistency of a trivalent subunit egg-based influenza vaccine in adults.
CHANG YT, Guo CY, Tsai MS, Cheng YY, et al.
Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
SCHEIFELE DW, Ward BJ, Dionne M, Vanderkooi OG, et al.
Compatibility of ASO3-adjuvanted H1N1pdm09 and seasonal trivalent influenza vaccines in adults: Results of a randomized, controlled trial.
HUTCHINSON EC, Fodor E.
Nuclear import of the influenza A virus transcriptional machinery.
SWAYNE DE, Eggert D, Beck JR.
Reduction of high pathogenicity avian influenza virus in eggs from chickens once or twice vaccinated with an oil-emulsified inactivated H5 avian influenza vaccine.
QUAN FS, Kim MC, Lee BJ, Song JM, et al.
Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection.
ABED Y, Pizzorno A, Boivin G.
Therapeutic Activity of Intramuscular Peramivir in Mice Infected with a Recombinant Influenza A/WSN/33 (H1N1) Virus Containing the H275Y Neuraminidase Mutation.
-
------
Research Articles Abstracts ? June 16 2012 Issue
Research Articles Abstracts ? June 16 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts ? June 16 2012 Issue Abstracts List
Pebody RG, Andrews N, Fleming DM, McMenamin J, et al.
Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom.
Henning J, Morton JM, Wibawa H, Yulianto D, et al.
Incidence and risk factors for H5 highly pathogenic avian influenza infection in flocks of apparently clinically healthy ducks.
Sayers G, Igoe D, Carr M, Cosgrave M, et al.
High morbidity and mortality associated with an outbreak of influenza A(H3N2) in a psycho-geriatric facility.
Redlberger-Fritz M, Aberle JH, Popow-Kraupp T, Kundi M, et al.
Attributable deaths due to influenza: a comparative study of seasonal and pandemic influenza.
Tacon CE, Newton R, Proud D, Leigh R, et al.
Rhinovirus-induced MMP-9 expression is dependent on Fra-1, which is modulated by formoterol and dexamethasone.
Newcomb DC, Boswell MG, Huckabee MM, Goleniewska K, et al.
IL-13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner.
Zhou J, To KK, Dong H, Cheng ZS, et al.
A functional variation in CD55 gene increases the disease severity of pandemic A(H1N1)2009 influenza infection.
Moisy D, Avilov SV, Jacob Y, Laoide BM, et al.
HMGB1 protein binds to influenza virus nucleoprotein and promotes viral replication.
Nelson MI, Vincent AL, Kitikoon P, Holmes EC, et al.
The evolution of novel reassortant A/H3N2 influenza viruses in North American swine and humans, 2009-2011.
Weeks-Gorospe JN, Hurtig HR, Iverson AR, Schuneman MJ, et al.
Naturally occurring swine influenza A virus PB1-F2 phenotypes that contribute to super-infection with Gram-positive respiratory pathogens.
Varga ZT, Grant A, Manicassamy B, Palese P, et al.
The Influenza Virus Protein PB1-F2 Inhibits the Induction of Type I Interferon by Binding to MAVS and Decreasing the Mitochondrial Membrane Potential.
Yang H, Carney PJ, Donis RO, Stevens J, et al.
Structure and receptor complexes of the hemagglutinin from a highly pathogenic H7N7 influenza virus.
O'Donnell CD, Wright A, Vogel L, Wei CJ, et al.
The effect of priming with H1N1 influenza viruses of variable antigenic distance on challenge with 2009 pandemic H1N1 virus.
Enquist LW.
Select agent publications and the H5N1 influenza virus controversy: a Journal of Virology Perspective.
Schrauwen EJ, Herfst S, Leijten LM, van Run P, et al.
The multibasic cleavage site in H5N1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets.
Harrison MS, Schmitt PT, Pei Z, Schmitt AP, et al.
Role of ubiquitin in parainfluenza virus 5 particle formation.
Jian-Umpunkul P, Thepthai C, Apiwat N, Chantima W, et al.
Improved sensitivity of Influenza A antigen detection using a combined NP, M, and NS1 sandwich ELISA.
.. .
Update: influenza activity - United States, 2011-12 season and composition of the 2012-13 influenza vaccine. Luytjes W, Enouf V, Schipper M, Gijzen K, et al.
HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains.
Wilks S, de Graaf M, Smith DJ, Burke DF, et al.
A review of influenza haemagglutinin receptor binding as it relates to pandemic properties.
-
-------
Research Articles Abstracts?June 23 2012 Issue
Research Articles Abstracts?June 23 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?June 23 2012 Issue Abstracts List
Kmietowicz Z.
Research on potential of bird flu virus to spread between humans is finally published.
Tsui HY, Lau JT, Lin C, Choi KC, et al.
Prevalence of seasonal influenza vaccination and associated factors in people with chronic diseases in Hong Kong.
Croville G, Soubies SM, Barbieri J, Klopp C, et al.
Field Monitoring of Avian Influenza Viruses: Whole Genome Sequencing and Tracking of Neuraminidase Evolution Using 454 Pyrosequencing.
Nivin B, Zancocchio T.
Cluster of False-Positive Influenza B Rapid Antigen Tests in a New York City Hospital.
Westgeest KB, de Graaf M, Fourment M, Bestebroer TM, et al.
Genetic Evolution of Neuraminidase of Influenza A (H3N2) Viruses from 1968 to 2009 and its Correspondence to Hemagglutinin.
Mgbemena V, Segovia JA, Chang TH, Tsai SY, et al.
Transactivation of Inducible Nitric Oxide Synthase Gene by Kruppel-like Factor 6 Regulates Apoptosis during Influenza A Virus Infection.
Xu R, Zhu X, McBride R, Nycholat CM, et al.
Functional Balance of the Hemagglutinin and Neuraminidase Activities Accompanies the Emergence of the 2009 H1N1 Influenza Pandemic.
Qi L, Davis AS, Jagger BW, Schwartzman LM, et al.
Analysis by single gene reassortment demonstrates that the 1918 influenza virus is functionally compatible with a low pathogenicity avian influenza virus in mice.
Nelli RK, Dunham SP, Kuchipudi SV, White GA, et al.
Mammalian Innate Resistance to Highly Pathogenic Avian Influenza H5N1 Virus Infection is Mediated through Reduced Pro-inflammation and Infectious Virus Release.
Babon JA, Cruz J, Ennis FA, Yin L, et al.
A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A subtypes and to influenza B virus.
Brock LG, Karron RA, Krempl CD, Collins PL, et al.
Evaluation of pneumonia virus of mice as a possible human pathogen.
Ioannidis I, McNally B, Willette M, Peeples ME, et al.
Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection.
Verma N, Dimitrova M, Carter DM, Crevar CJ, et al.
Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children.
Zeng R, Zhang H, Hai Y, Cui Y, et al.
IL-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses.
Gordon DL, Sajkov D, Woodman RJ, Honda-Okubo Y, et al.
Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax polysaccharide adjuvant.
Sullender W, Fowler K, Krishnan A, Gupta V, et al.
Design and initiation of a study to assess the direct and indirect effects of influenza vaccine given to children in rural India.
Isken B, Genzel Y, Reichl U.
Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants.
Xu K, Ferreri L, Rimondi A, Olivera V, et al.
Isolation and characterization of an H9N2 influenza virus isolated in Argentina.
Bulkow LR, Singleton RJ, DeByle C, Miernyk K, et al.
Risk factors for hospitalization with lower respiratory tract infections in children in rural Alaska.
-
-------
Research Articles Abstracts?June 30 2012 Issue
Research Articles Abstracts?June 30 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?June 30 2012 Issue Abstracts List
Yong E.
Trials at the ready: preparing for the next pandemic.
Sun Z, Huber V, McCormick K, Kaushik RS, et al.
Characterization of a porcine intestinal epithelial cell line for influenza virus production.
van Asten L, van den Wijngaard C, van Pelt W, van de Kassteele J, et al.
MORTALITY ATTRIBUTABLE TO 9 COMMON INFECTIONS: significant effect of influenza A, RSV, influenza B, norovirus and parainfluenza in the elderly.
Inagaki A, Goto H, Kakugawa S, Ozawa M, et al.
Competitive incorporation of homologous gene segments of influenza A virus into virions.
Vanderlinden E, Vanstreels E, Boons E, Ter Veer W, et al.
Intracytoplasmic trapping of influenza virus by a lipophilic derivative of aglycoristocetin.
Zhang Y, Zhang Q, Gao Y, He X, et al.
Key molecular factors in HA and PB2 contribute to the efficient transmission of the 2009 H1N1 pandemic influenza virus.
Jiao P, Wei L, Yuan R, Song Y, et al.
Complete Genome Sequence of an H7N3 Avian Influenza Virus Isolated from Ducks in Southern China.
Jiao P, Yuan R, Song Y, Wei L, et al.
Full Genome Sequence of a Recombinant H5N1 Influenza Virus from a Condor in Southern China.
Jiao P, Yuan R, Wei L, Jia B, et al.
Complete Genomic Sequence of a Novel Natural Recombinant H6N2 Influenza Virus from Chickens in Guangdong, Southern China.
Jiao P, Cao L, Yuan R, Wei L, et al.
Complete Genome Sequence of an H10N8 Avian Influenza Virus Isolated from a Live Bird Market in Southern China.
Lombardo T, Dotti S, Renzi S, Ferrari M, et al.
Susceptibility of different cell lines to Avian and Swine Influenza viruses.
Sancho A, Melchiorri D, Abadie E.
More on influenza vaccine in young children.
Catlin EA, Warren HS, Shailam R, Lahoud-Rahme M, et al.
Case records of the Massachusetts General Hospital. Case 19-2012. A premature newborn boy with respiratory distress.
Honda-Okubo Y, Saade F, Petrovsky N.
Advax, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses.
Li S, Zhu J.
Are the atypical forms of Guillain-Barre syndrome correlated with H1N1-influenza vaccination?
De Vleeschauwer AR, Baras B, Kyriakis CS, Jacob V, et al.
Efficacy of an AS03(A)-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs.
Huang WT, Huang WI, Huang YW, Hsu CW, et al.
The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture-recapture analysis.
Weston WM, Friedland LR, Wu X, Howe B, et al.
Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix((R))): Results of two randomized trials.
Tandale BV, Pawar SD, Mishra AC.
Immunogenicity and safety of pandemic H1N1 2009 vaccine among adults in field use, India.
Easterbrook JD, Schwartzman LM, Gao J, Kash JC, et al.
Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice.
-
------
Research Articles Abstract?July 7 2012 Issue
Research Articles Abstract?July 7 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstract?July 7 2012 Issue Abstract List
Fisman DN.
Getting schooled: school closure, age distribution, and pandemic mitigation.
Arafa A, Suarez D, Kholosy SG, Hassan MK, et al.
Evolution of highly pathogenic avian influenza H5N1 viruses in Egypt indicating progressive adaptation.
Hai-Bo W, Ru-Feng L, En-Kang W, Jin-Biao Y, et al.
Sequence and phylogenetic analysis of H7N3 avian influenza viruses isolated from poultry in China in 2011.
Giles BM, Crevar CJ, Carter DM, Bissel SJ, et al.
A Computationally-Optimized Hemagglutinin VLP Vaccine Elicits Broadly-Reactive Antibodies that Protect Non-Human Primates from H5N1 Infection.
Tarbet EB, Dorward JT, Day CW, Rashid KA, et al.
Vaccine production training to develop the workforce of foreign institutions supported by the BARDA influenza vaccine capacity building program.
Bliu A, Lemieux M, Li C, Li X, et al.
Modifying the thermostability of inactivated influenza vaccines.
Eppes C, Wu A, Cameron KA, Garcia P, et al.
Does obstetrician knowledge regarding influenza increase HINI vaccine acceptance among their pregnant patients?
Cheng X, Zengel JR, Xu Q, Jin H, et al.
Surface glycoproteins of influenza A H3N2 virus modulate virus replication in the respiratory tract of ferrets.
-
------
Research Articles Abstracts?July 14 2012 Issue
Research Articles Abstracts?July 14 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?July 14 2012 Issue Abstracts List
SCHUCHAT A, Katz JM.
Protecting Adults from Influenza: Tis the Season to Learn from the Pandemic.
JACKSON LA, Chen WH, Stapleton JT, Dekker CL, et al.
Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given with and without AS03 Adjuvant System in Healthy Adults and Seniors.
HSIANG TY, Zhou L, Krug RM.
Roles of the phosphorylation of specific serines and threonines in the NS1 protein of human influenza A viruses.
LIN L, Liu Q, Berube N, Detmer S, et al.
5' triphosphate-siRNA: potent inhibition of influenza A virus infection by gene silencing and RIG-I activation.
KRAMMER F, Pica N, Hai R, Tan GS, et al.
Hemagglutinin stalk reactive antibodies are boosted following sequential infection with seasonal and pandemic H1N1 influenza virus in mice.
RUCKLE A, Haasbach E, Julkunen I, Planz O, et al.
The NS1 protein of influenza A virus blocks RIG-I mediated activation of the noncanonical NF-kappaB pathway and p52/RelB dependent gene expression in lung epithelial cells.
STEINHOFF MC, MacDonald NE.
Influenza pandemics--pregnancy, pathogenesis, and perinatal outcomes.
DE WALS P, Deceuninck G, Toth E, Boulianne N, et al.
Risk of Guillain-Barre syndrome following H1N1 influenza vaccination in Quebec.
PASTERNAK B, Svanstrom H, Molgaard-Nielsen D, Krause TG, et al.
Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy.
LANGLOIS RA, Varble A, Chua MA, Garcia-Sastre A, et al.
Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses.
COHEN S, Janicki-Deverts D, Doyle WJ, Miller GE, et al.
Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk.
BLONDEL B, Mahjoub N, Drewniak N, Launay O, et al.
Failure of the vaccination campaign against A(H1N1) influenza in pregnant women in France: Results from a national survey.
CANDELA S, Pergolizzi S, Ragni P, Cavuto S, et al.
An early (3-6 weeks) active surveillance study to assess the safety of pandemic influenza vaccine Focetria((R)) in a province of Emilia-Romagna region, Italy - Part one.
WANITCHANG A, Narkpuk J, Jaru-Ampornpan P, Jengarn J, et al.
Inhibition of influenza A virus replication by influenza B virus nucleoprotein: An insight into interference between influenza A and B viruses.
TERRIER O, Moules V, Carron C, Cartet G, et al.
The influenza fingerprints: NS1 and M1 proteins contribute to specific host cell ultrastructure signatures upon infection by different influenza A viruses.
We have screened the following journals for you:
Am J Med
Ann Intern Med
Antimicrob Agents Chemother
Antiviral Res
Arch Intern Med
Arch Virol
Biochem Biophys Res Commun
Biochem Soc Trans
Biochemistry
BMJ
Cell
Clin Diagn Lab Immunol
Commun Dis Rep CDR Wkly
Drug Saf
Drugs
Epidemiol Infect
Eur J Epidemiol
J Clin Microbiol
J Epidemiol Community Health
J Exp Med
J Gen Virol
J Immunol
J Infect
J Infect Dis
J Virol
J Virol Methods
JAMA
Lancet
MMWR Morb Mortal Wkly Rep
N Engl J Med
Pediatrics
Proc Natl Acad Sci U S A
Vaccine
Virology
Virus Res
-
-------
Research Articles Abstracts?July 21 2012 Issue
Research Articles Abstracts?July 21 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?July 21 2012 Issue Abstracts List
Kheiri MT, Jamali A, Shenagari M, Hashemi H, et al.
Influenza virosome/DNA vaccine complex as a new formulation to induce intra-subtypic protection against influenza virus challenge.
Smee DF, Julander JG, Bart Tarbet E, Gross M, et al.
Treatment of Oseltamivir-Resistant Influenza A (H1N1) Virus Infections in Mice With Antiviral Agents.
Mon PP, Lapkuntod J, Maw MT, Nuansrichay B, et al.
Highly pathogenic avian influenza (H5N1) in Myanmar, 2006-2010.
Lugner AK, van Boven M, de Vries R, Postma MJ, et al.
Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
Plosker GL.
A/H5N1 Prepandemic Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated) [Vepacel(R)].
Benoit SR, Burkom H, McIntyre AF, Kniss K, et al.
Pneumonia in US hospitalized patients with influenza-like illness: BioSense, 2007-2010.
Freitas FT, Cabral AP, Barros EN, Burigo MJ, et al.
Pre-symptomatic transmission of pandemic influenza H1N1 2009: investigation of a family cluster, Brazil.
Arnold ME, Irvine RM, Tearne O, Rae D, et al.
Investigation into sampling strategies in response to potential outbreaks of low pathogenicity notifiable avian influenza initiated in commercial duck holdings in Great Britain.
Gubbels S, Krause TG, Bragstad K, Perner A, et al.
Burden and characteristics of influenza A and B in Danish intensive care units during the 2009/10 and 2010/11 influenza seasons.
Watanabe Y, Ibrahim MS, Ellakany HF, Kawashita N, et al.
Antigenic Analysis of Highly Pathogenic Avian Influenza Virus H5N1 Sublineages Co-Circulating in Egypt.
Nelson M, Gramer M, Vincent A, Holmes EC, et al.
Global transmission of influenza viruses from humans to swine.
Frey SE, Bernstein DI, Gerber MA, Keyserling HL, et al.
Safety and Immune Responses in Children after Concurrent or Sequential 2009 H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations.
Lichenstein R, Magder LS, King RE, King JC Jr, et al.
The relationship between influenza outbreaks and acute ischemic heart disease in Maryland residents over a seven-year period.
Vincent AL, Ma W, Lager KM, Richt JA, et al.
Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine associated enhanced respiratory disease.
Hamilton BS, Gludish DW, Whittaker GR.
Cleavage Activation of the Human-Adapted Influenza Virus Subtypes by Matriptase Reveals Both Subtype- and Strain-Specificity.
Wong DD, Choy KT, Chan RW, Sia SF, et al.
Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.
Miyoshi-Akiyama T, Akasaka Y, Oogane T, Kondo Y, et al.
Development and Evaluation of a Line Probe Assay for Rapid Typing of Influenza Viruses and Detection of the H274Y Mutation.
de-Paris F, Beck C, Machado AB, Paiva RM, et al.
Optimization of one-step duplex real-time rt-pcr for detection of influenza and respiratory syncytial virus in nasopharyngeal aspirates.
Lung O, Beeston A, Ohene-Adjei S, Pasick J, et al.
Electronic microarray assays for avian influenza and Newcastle disease virus.
Houspie L, Keyaerts E, Maes P, Van Ranst M, et al.
Susceptibility of the PER.C6 cell line for infection with clinical human respiratory syncytial virus isolates.
Taylor DN, Treanor JJ, Sheldon EA, Johnson C, et al.
Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response.
Dominguez A, Castilla J, Godoy P, Delgado-Rodriguez M, et al.
Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization.
Boonnak K, Paskel M, Matsuoka Y, Vogel L, et al.
Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in non-human primates.
Newall AT, Dehollain JP, Wood JG.
Under-explored assumptions in influenza vaccination models: Implications for the universal vaccination of children.
Maltezou HC, Kallogeropoulou C, Pergialiotis V, Siahanidou T, et al.
Acceptance of a post-partum influenza vaccination (cocooning) strategy for neonates in Greece.
Hung IF, Levin Y, To KK.
Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 H1N1 vaccination.
Ducatez MF, Ilyushina NA, Fabrizio TP, Rehg JE, et al.
Both influenza hemagglutinin and polymerase acidic genes are important for delayed pandemic 2009 H1N1 virus clearance in the ferret model.
-
-------
Research Articles Abstracts?July 28 2012 Issue
Research Articles Abstracts?July 28 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?July 28 2012 Issue Abstracts List
St Louis C, Zorlu G.
Can Twitter predict disease outbreaks?
Kmietowicz Z.
Lack of warnings over flu may have led to more deaths in year after pandemic, say experts.
Huang P, Liang LJ, Hou NM, Zhang X, et al.
Phylogenetic, molecular and drug-sensitivity analysis of HA and NA genes of human H3N2 influenza A viruses in Guangdong, China, 2007-2011.
Rajatonirina S, Rakotosolofo B, Rakotomanana F, Randrianasolo L, et al.
Excess mortality associated with the 2009 A(H1N1)v influenza pandemic in Antananarivo, Madagascar.
Pena L, Vincent AL, Loving CL, Henningson JN, et al.
Strain-dependent Effects of PB1-F2 of Triple Reassortant H3N2 Influenza Viruses in Swine.
Gutierrez-Pizarraya A, Perez-Romero P, Alvarez R, Aydillo TA, et al.
Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave.
Loeb M, Singh PK, Fox J, Russell ML, et al.
Longitudinal Study of Influenza Molecular Viral Shedding in Hutterite Communities.
Niemann S, Ehrhardt C, Medina E, Warnking K, et al.
The Combined Action of Influenza Virus and Staphylococcus aureus Panton-Valentine Leukocidin Provokes Severe Lung Epithelium Damage.
Azziz Baumgartner E, Dao C, Nasreen S, Bhuiyan MU, et al.
Seasonality, timing, and climate drivers of influenza activity worldwide.
Weinheimer VK, Becher A, Tonnies M, Holland G, et al.
Influenza A viruses target type II pneumocytes in the human lung.
Cheung CY, Chan EY, Krasnoselsky A, Purdy D, et al.
H5N1 Virus Causes Significant Perturbations in Host Proteome Very Early in Influenza Virus-Infected Primary Human Monocyte-Derived Macrophages.
Malur M, Gale M Jr, Krug RM.
LGP2 Downregulates Interferon Production During Infection By Seasonal Human Influenza A Viruses That Activate IRF3.
Leung HS, Li OT, Chan RW, Chan MC, et al.
The virus entry of influenza A virus with a alpha2,6-linked sialic acid binding preference requires host fibronectin.
Jeisy-Scott V, Kim JH, Davis WG, Cao W, et al.
TLR7 recognition is dispensable for influenza virus A infection, but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice.
.. .
Notes from the Field: Outbreak of Influenza A (H3N2) Virus Among Persons and Swine at a County Fair - Indiana, July 2012. Loving CL, Vincent AL, Pena L, Perez DR, et al.
Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs.
van Riet E, Ainai A, Suzuki T, Hasegawa H, et al.
Mucosal IgA responses in influenza virus infections; thoughts for vaccine design.
Nowalk MP, Nutini J, Raymund M, Ahmed F, et al.
Evaluation of a toolkit to introduce standing orders for influenza and pneumococcal vaccination in adults: A multimodal pilot project.
Hunt C, Arthur A.
Student nurses' reasons behind the decision to receive or decline influenza vaccine: A cross-sectional survey.
Ortqvist A, Bennet R, Rinder MR, Lindblad H, et al.
Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza.
Puig-Barbera J, Diez-Domingo J, Arnedo-Pena A, Ruiz-Garcia M, et al.
Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case-case comparison, case-control study.
MacIntyre CR, Ridda I, Seale H, Gao Z, et al.
Respiratory viruses transmission from children to adults within a household.
Nguyen T, Rivailler P, Davis CT, Thi Hoa D, et al.
Evolution of highly pathogenic avian influenza (H5N1) virus populations in Vietnam between 2007 and 2010.
Scagnolari C, Midulla F, Riva E, Monteleone K, et al.
Evaluation of interleukin 28B single nucleotide polymorphisms in infants suffering from bronchiolitis.
-
-------
Research Articles Abstracts?August 4 2012 Issue
Research Articles Abstracts?August 4 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?August 4 2012 Issue Abstracts List
Guan Z, Shi N, Song Y, Zhang X, et al.
Induction of the cellular microRNA-29c by influenza virus contributes to virus-mediated apoptosis through repression of antiapoptotic factors BCL2L2.
Hong SB, Choi EY, Kim SH, Suh GY, et al.
Epidemiological analysis of critically ill adult patients with pandemic influenza A(H1N1) in South Korea.
Raoult D.
Non transmissible diseases are often transmissible.
Cao W, Taylor AK, Biber RE, Davis WG, et al.
Rapid Differentiation of Monocytes into Type I IFN-Producing Myeloid Dendritic Cells as an Antiviral Strategy against Influenza Virus Infection.
Verma A, White M, Vathipadiekal V, Tripathi S, et al.
Human H-Ficolin Inhibits Replication of Seasonal and Pandemic Influenza A Viruses.
Uzicanin A, Thompson M, Smith P, Chaves SS, et al.
Effectiveness of One Dose of Influenza A (H1N1) 2009 Monovalent Vaccines in Preventing RT-PCR-confirmed H1N1 Infection among School-aged Children in Maine, USA.
Osterlund P, Strengell M, Sarin LP, Poranen MM, et al.
Incoming Influenza A Virus Evades the Early Host Recognition - Direct Interferon Induction by Influenza B Virus Entry.
Josset L, Engelmann F, Haberthur K, Kelly S, et al.
Increased viral loads and exacerbated innate host response in aged macaques infected with 2009 pandemic H1N1 influenza A virus.
Kawaguchi A, Matsumoto K, Nagata K.
YB-1, Y-box binding protein-1, is a porter to lead influenza virus ribonucleoprotein complexes to microtubules.
Jiao P, Song Y, Yuan R, Wei L, et al.
Complete Genomic Sequence of an H5N1 Influenza Virus from a Parrot in Southern China.
Jiao P, Wei L, Yuan R, Gong L, et al.
Complete Genome Sequence of an H5N2 Avian Influenza Virus Isolated from a Parrot in Southern China.
Dimaio MA, Sahoo MK, Waggoner J, Pinsky BA, et al.
Comparison of Xpert Flu Rapid Nucleic Acid Testing with Rapid Antigen Testing for the Diagnosis of Influenza A and B.
Geeraedts F, Ter Veer W, Wilschut J, Huckriede A, et al.
Effect of viral membrane fusion activity on antibody induction by influenza H5N1 whole inactivated virus vaccine.
Tennis P, Toback SL, Andrews EB, McQuay LJ, et al.
A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009-2010 season.
Noble E, Cox A, Deval J, Kim B, et al.
Endonuclease substrate selectivity characterized with full-length PA of influenza A virus polymerase.
Sendelbach DM, Sanchez PJ.
Varicella, influenza: not necessary to separate mother and infant.
-
-------
Research Articles Abstracts?August 11 2012 Issue
Research Articles Abstracts?August 11 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?August 11 2012 Issue Abstracts List
TOME L, Frabasile S, Candia C, Pittini A, et al.
Selection and characterization of human respiratory syncytial virus escape mutants resistant to a polyclonal antiserum raised against the F protein.
BAEK YH, Choi EH, Song MS, Pascua PN, et al.
Prevalence and genetic characterization of respiratory syncytial virus (RSV) in hospitalized children in Korea.
QIAO C, Liu Q, Bawa B, Shen H, et al.
Pathogenicity and transmissibility of reassortant H9 influenza viruses with genes from pandemic H1N1 virus.
CHO JL, Roche MI, Sandall B, Brass AL, et al.
Enhanced Tim3 Activity Improves Survival after Influenza Infection.
GE MQ, Ho AW, Tang Y, Wong KH, et al.
NK Cells Regulate CD8+ T Cell Priming and Dendritic Cell Migration during Influenza A Infection by IFN-gamma and Perforin-Dependent Mechanisms.
GUERVILLY C, Roch A, Ranque S, Forel JM, et al.
A strategy based on galactomannan antigen detection and PCR for invasive pulmonary aspergillosis following influenza A (H1N1) pneumonia.
SKOWRONSKI DM, Janjua NZ, De Serres G, Purych D, et al.
Cross-reactive and vaccine-induced antibody to emerging swine influenza A(H3N2)v.
HANSEN C, Desai S, Bredfeldt C, Cheetham C, et al.
A large population-based study of pandemic influenza A H1N1 diagnosis during pregnancy and maternal and neonatal outcomes.
ROSSMAN JS, Leser GP, Lamb RA.
Filamentous Influenza Virus Enters Cells Via Macropinocytosis.
BENNETT JA, Prince LR, Parker LC, Stokes CA, et al.
Pellino-1 selectively regulates epithelial cell responses to rhinovirus.
ZHOU F, Wang G, Buchy P, Cai Z, et al.
A Tri-Clade DNA Vaccine Designed on the Basis of a Comprehensive Serologic Study Elicits Neutralizing Antibody Responses against All Clades and Subclades of HPAI H5N1 Viruses.
SUBATHRA M, Santhakumar P, Lingaraja K, Narasu ML, et al.
Recombinant haemagglutinin protein of highly pathogenic avian influenza A (H5N1) virus expressed in Pichia pastoris elicits a neutralizing antibody response in mice.
JOKELA P, Piiparinen H, Mannonen L, Auvinen E, et al.
Performance of the Luminex xTAG Respiratory Viral Panel Fast in a clinical laboratory setting.
KIM JH, Davis WG, Sambhara S, Jacob J, et al.
Strategies to alleviate original antigenic sin responses to influenza viruses.
SIEBEN C, Kappel C, Zhu R, Wozniak A, et al.
Influenza virus binds its host cell using multiple dynamic interactions.
KATSURA H, Iwatsuki-Horimoto K, Fukuyama S, Watanabe S, et al.
A replication-incompetent virus possessing an uncleavable hemagglutinin as an influenza vaccine.
We have screened the following journals for you:
Am J Med
Ann Intern Med
Antimicrob Agents Chemother
Antiviral Res
Arch Intern Med
Arch Virol
Biochem Biophys Res Commun
Biochem Soc Trans
Biochemistry
BMJ
Cell
Clin Diagn Lab Immunol
Commun Dis Rep CDR Wkly
Drug Saf
Drugs
Epidemiol Infect
Eur J Epidemiol
J Clin Microbiol
J Epidemiol Community Health
J Exp Med
J Gen Virol
J Immunol
J Infect
J Infect Dis
J Virol
J Virol Methods
JAMA
Lancet
MMWR Morb Mortal Wkly Rep
N Engl J Med
Pediatrics
Proc Natl Acad Sci U S A
Vaccine
Virology
Virus Res
-
-------
Research Articles Abstracts?August 18 2012 Issue
Research Articles Abstracts?August 18 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?August 18 2012 Issue Abstracts List
SRIWILAIJAROEN N, Fukumoto S, Kumagai K, Hiramatsu H, et al.
Antiviral effects of Psidium guajava Linn. (guava) tea on the growth of clinical isolated H1N1 viruses: its role in viral hemagglutination and neuraminidase inhibition.
DOREA FC, Cole DJ, Stallknecht DE.
Quantitative exposure assessment of waterfowl hunters to avian influenza viruses.
SHORT KR, Brooks AG, Reading PC, Londrigan SL, et al.
The fate of influenza A virus after infection of human macrophages and dendritic cells.
PRITCHARD AL, Carroll ML, Burel JG, White OJ, et al.
Innate IFNs and Plasmacytoid Dendritic Cells Constrain Th2 Cytokine Responses to Rhinovirus: A Regulatory Mechanism with Relevance to Asthma.
PATEL SM, Atmar RL, El Sahly HM, Guo K, et al.
Direct Comparison of an Inactivated Subvirion Influenza A Virus Subtype H5N1 Vaccine Administered by the Intradermal and Intramuscular Routes.
SCHNEEMANN A, Speir JA, Tan GS, Khayat R, et al.
A Virus-like Particle that Elicits Cross-reactive Antibodies to the Conserved Stem of Influenza Virus Hemagglutinin.
IMAI M, Watanabe S, Kawaoka Y.
The Cytoplasmic Tail Domain of Influenza B Virus Hemagglutinin Is Important for Its Incorporation into Virions but Is Not Essential for Virus Replication in Cell Culture in the Presence of Compensatory Mutations.
TAKAHASHI E, Kataoka K, Indalao IL, Konoha K, et al.
Oral clarithromycin enhances airway IgA immunity through induction of IgA class switching recombination and B-cell activating factor of the tumor necrosis factor family molecule on mucosal dendritic cells in mice infected with influenza A virus.
TIAN J, Zhang C, Qi W, Xu C, et al.
Genome Sequence of a Novel Reassortant H3N2 Avian Influenza Virus in Southern China.
PARK SJ, Moon HJ, Kang BK, Hong M, et al.
Complete Genome Sequence of an Avian-Origin H3N2 Canine Influenza Virus Isolated from Dogs in South Korea.
SU S, Qi WB, Chen JD, Cao N, et al.
Complete Genome Sequence of an Avian-Like H4N8 Swine Influenza Virus Discovered in Southern China.
SU S, Chen JD, Qi HT, Zhu WJ, et al.
Complete Genome Sequence of a Novel Avian-Like H3N2 Swine Influenza Virus Discovered in Southern China.
?
Evaluation of Rapid Influenza Diagnostic Tests for Influenza A (H3N2)v Virus and Updated Case Count - United States, 2012.
?.
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) - United States, 2012-13 Influenza Season.
WILLIAMS WW, Lu PJ, Lindley MC, Kennedy ED, et al.
Influenza vaccination coverage among adults--National Health Interview Survey, United States, 2008-09 influenza season.
HUANG JW, Lin WF, Yang JM.
Antigenic sites of H1N1 influenza virus hemagglutinin revealed by natural isolates and inhibition assays.
LUISA MM, Lucia N, Claudio V, Simona DM, et al.
A population based cohort study to assess the safety of pandemic influenza vaccine Focetria((R)) in Emilia-Romagna region, Italy-Part Two. Vaccine. 2012.
VENTURA R, Brunner L, Heriyanto B, de Boer O, et al.
Technology transfer of an oil-in-water vaccine-adjuvant for strengthening pandemic influenza preparedness in Indonesia.
VAN DER VELDEN MV, Aichinger G, Pollabauer EM, Low-Baselli A, et al.
Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: Homologous or heterologous booster response following two dose or single dose priming.
POLAND GA, Jacobsen SJ.
Influenza vaccine, Guillain-Barre syndrome, and chasing zero.
DUVVURI VR, Marchand-Austin A, Eshaghi A, Patel SN, et al.
Potential T cell epitopes within swine-origin triple reassortant influenza A (H3N2) variant virus which emerged in 2011: An immunoinformatics study.
We have screened the following journals for you:
Am J Med
Ann Intern Med
Antimicrob Agents Chemother
Antiviral Res
Arch Intern Med
Arch Virol
Biochem Biophys Res Commun
Biochem Soc Trans
Biochemistry
BMJ
Cell
Clin Diagn Lab Immunol
Commun Dis Rep CDR Wkly
Drug Saf
Drugs
Epidemiol Infect
Eur J Epidemiol
J Clin Microbiol
J Epidemiol Community Health
J Exp Med
J Gen Virol
J Immunol
J Infect
J Infect Dis
J Virol
J Virol Methods
JAMA
Lancet
MMWR Morb Mortal Wkly Rep
N Engl J Med
Pediatrics
Proc Natl Acad Sci U S A
Vaccine
Virology
Virus Res
-
------
Research Articles Abstracts?August 25 2012 Issue
Research Articles Abstracts?August 25 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?August 25 2012 Issue Abstracts List
Escuret V, Cornu C, Boutitie F, Enouf V, et al.
Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) influenza virus infections.
Murphy H.
Vaccinating healthy children against flu is cost effective, says committee.
Beck CR, McKenzie BC, Hashim AB, Harris RC, et al.
Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by aetiology.
Ilyushina NA, Ikizler MR, Kawaoka Y, Rudenko LG, et al.
Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium.
Hung IF, Levin Y, To KK, Chan KH, et al.
Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain.
Kumagai T, Kiyono H.
Summary for Symposium I on the Development of a More Efficacious Influenza Vaccine Held at the 15th Annual Meeting of the Japanese Society for Vaccinology, Tokyo, 2011.
Coleman BL, McGeer AJ, Halperin SA, Langley JM, et al.
A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine.
Qian C, Chen S, Ding P, Chai M, et al.
The immune response of a recombinant fowlpox virus coexpressing the HA gene of the H5N1 highly pathogenic avian influenza virus and chicken interleukin 6 gene in ducks.
Reynales H, Astudillo P, de Valliere S, Hatz C, et al.
A prospective observational safety study on MF59((R)) adjuvanted cell culture-derived vaccine, Celtura((R)) during the A/H1N1 (2009) influenza pandemic.
Hiromoto Y, Parchariyanon S, Ketusing N, Netrabukkana P, et al.
Isolation of the Pandemic (H1N1) 2009 virus and its reassortant with an H3N2 swine influenza virus from healthy weaning pigs in Thailand in 2011.
Muratore G, Mercorelli B, Goracci L, Cruciani G, et al.
The Human Cytomegalovirus Inhibitor AL18 Also Possesses Activity against Influenza A and B Viruses.
-
-------
Research Articles Abstracts?September 3 2012 Issue
Research Articles Abstracts?September 3 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?September 3 2012 Issue Abstracts List
Schoene CU, Staubach C, Grund C, Globig A, et al.
Towards a new, ecologically targeted approach to monitoring wild bird populations for avian influenza viruses.
Ogata N.
Inactivation of influenza virus hemagglutinin by chlorine dioxide: oxidation of conserved tryptophan 153 residue in the receptor binding site.
Chan YF, Jafar FL, Nathan AM, de Bruyne JA, et al.
Diverse human rhinoviruses A and C from children with respiratory infections in Kuala Lumpur, Malaysia.
Cheng X, Tan Y, He M, Lam TT, et al.
Epidemiological dynamics and phylogeography of influenza in southern China.
Mascitelli L, Grant WB, Goldstein MR.
Obesity, influenza virus infection, and hypovitaminosis D.
Chan PK, Lee N, Zaman M, Adisasmito W, et al.
Determinants of Antiviral Effectiveness in H5N1 Avian Influenza.
Jackson LA, Nelson JC.
Association between statins and mortality.
Papenburg J, Hamelin ME, Ouhoummane N, Carbonneau J, et al.
Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children.
Pedersen GK, Madhun AS, Breakwell L, Hoschler K, et al.
Th1 Cells Elicited by H5N1 Vaccination Predict Seroprotection.
Cao S, Shi Y, Tan S, Song H, et al.
Reply to "Nuclear Export Signal and Immunodominant CD8+ T Cell Epitope in Influenza A Virus Matrix Protein 1".
Terajima M, Ennis FA.
Nuclear Export Signal and Immunodominant CD8+ T Cell Epitope in Influenza A Virus Matrix Protein 1.
Xie Q, Yan Z, Ji J, Zhang H, et al.
Complete Genome Sequence of a Novel H9N2 Subtype Influenza Virus FJG9 Strain in China Reveals a Natural Reassortant Event.
Su S, Cao N, Chen J, Zhao F, et al.
Complete Genome Sequence of an Avian-Origin H3N2 Canine Influenza A Virus Isolated in Farmed Dogs in Southern China.
Fereidouni SR, Harder TC, Gaidet N, Ziller M, et al.
Saving resources: Avian influenza surveillance using pooled swab samples and reduced reaction volumes in real-time RT-PCR.
Kingstad-Bakke B, Brewoo JN, Mai LQ, Kawaoka Y, et al.
Effects of route and co-administration of recombinant raccoon poxviruses on immune responses and protection against highly pathogenic avian influenza in mice.
Klimov AI, Garten R, Russell C, Barr IG, et al.
WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011.
Okuwa T, Muraki Y, Himeda T, Ohara Y, et al.
Glycosylation of CM2 is important for efficient replication of influenza C virus.
Escalera-Zamudio M, Cobian-Guemes G, de Los Dolores Soto-Del Rio M, Isa P, et al.
Characterization of an influenza A virus in Mexican swine that is related to the A/H1N1/2009 pandemic clade.
Hillaire ML, van Eijk M, Nieuwkoop NJ, van Trierum SE, et al.
The number and position of N-linked glycosylation sites in the hemagglutinin determine differential recognition of seasonal and 2009 pandemic H1N1 influenza virus by porcine surfactant protein D.
Tran D, Vaudry W, Moore DL, Bettinger JA, et al.
Comparison of Children Hospitalized With Seasonal Versus Pandemic Influenza A, 2004-2009.
Effler PV.
Every Year Is an Influenza Pandemic for Children: Can We Stop Them?
Blanton L, Peacock G, Cox C, Jhung M, et al.
Neurologic Disorders Among Pediatric Deaths Associated With the 2009 Pandemic Influenza.
-
-------
Research Articles Abstracts?September 8 2012 Issue
Research Articles Abstracts?September 8 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?September 8 2012 Issue Abstracts List
Schunemann HJ, Santesso N, Brozek J.
Antivirals for Treatment of Influenza.
Heneghan C, Jefferson T, Doshi P.
Antivirals for treatment of influenza.
Jones MA, Hama R, Del Mar C.
Antivirals for treatment of influenza.
Qi X, Cui L, Jiao Y, Pan Y, et al.
Antigenic and genetic characterization of a European avian-like H1N1 swine influenza virus from a boy in China in 2011.
d'Costa D.
Big brother with little evidence for mandatory vaccination of healthcare professionals.
Arnold ME, Slomka MJ, Coward VJ, Mahmood S, et al.
Evaluation of the pooling of swabs for real-time PCR detection of low titre shedding of low pathogenicity avian influenza in turkeys.
Taylor AK, Cao W, Vora KP, Cruz JD, et al.
Protein Energy Malnutrition Decreases Immunity and Increases Susceptibility to Influenza Infection in Mice.
van Wielink R, Harmsen MM, Martens DE, Peeters BP, et al.
Mutations in the M gene segment can substantially increase replication efficiency of NS1 deletion influenza A virus in MDCK cells.
Shi M, Jagger BW, Wise HM, Digard P, et al.
Evolutionary conservation of the PA-X open reading frame in segment 3 of influenza A virus.
Verma S, Dimtrova M, Munjal A, Fontana J, et al.
Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild type H5N1 influenza challenge and control viral loads better than subunit H5N1 vaccine by eliciting high affinity antibodies.
Li W, Moltedo B, Moran TM.
Type I IFN induction during influenza infection increases the susceptibility to secondary S. pneumoniae Infection by negative regulation of gammadelta T cells.
Edenborough KM, Gilbertson BP, Brown LE.
A mouse model for the study of contact-dependent transmission of influenza A virus and the factors that govern transmissibility.
Kowalczyk A, Markowska-Daniel I, Rasmussen TB.
Development of a primer-probe energy transfer based real-time PCR for the detection of Swine Influenza Virus.
Voelker R.
H3N2 flu virus infections increase during fair season.
Bose S, Zokarkar A, Welch BD, Leser GP, et al.
Fusion activation by a headless parainfluenza virus 5 hemagglutinin-neuraminidase stalk suggests a modular mechanism for triggering.
Wooten KG, Wortley PM, Singleton JA, Euler GL, et al.
Perceptions matter: Beliefs about influenza vaccine and vaccination behavior among elderly white, black and Hispanic Americans.
-
-------
Research Articles Abstracts?September 15 2012 Issue
Research Articles Abstracts?September 15 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?September 15 2012 Issue Abstracts List
Ganesan S, Faris AN, Comstock AT, Wang Q, et al.
Quercetin inhibits rhinovirus replication in vitro and in vivo.
Durrieu G, Palmaro A, Pourcel L, Caillet C, et al.
First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines: A Comparison of Reports Submitted by Patients and Healthcare Professionals.
Lycett SJ, Baillie G, Coulter E, Bhatt S, et al.
Estimating reassortment rates in co-circulating Eurasian swine influenza viruses.
El-Shesheny RA, Kayali G, Kandeil A, Cai Z, et al.
Antigenic diversity and cross-reactivity of avian influenza H5N1 viruses in Egypt between 2006 and 2011.
Pepin KM, Vandalen KK, Mooers NL, Ellis JW, et al.
Quantification of heterosubtypic immunity between avian influenza subtypes H3N8 and H4N6 in multiple avian host species.
Mok BW, Song W, Wang P, Tai H, et al.
The NS1 protein of influenza A virus interacts with cellular processing bodies (P-bodies) and stress granules through RNA-associated protein 55 (RAP55) during virus infection.
.. .
Notes from the Field: Highly Pathogenic Avian Influenza A (H7N3) Virus Infection in Two Poultry Workers - Jalisco, Mexico, July 2012. Liu X, Guo J, Han S, Yao L, et al.
Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin.
Schaap-Nutt A, Liesman R, Bartlett EJ, Scull MA, et al.
Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium.
.. .
Recommendations for Prevention and Control of Influenza in Children, 2012-2013. -
-------
Research Articles Abstracts?September 22 2012 Issue
Research Articles Abstracts?September 22 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?September 22 2012 Issue Abstracts List
Smieja M.
Review: Oseltamivir relieves symptoms but does not reduce hospitalizations in influenza.
Zhao X, Jie Y, Rosenberg MR, Wan J, et al.
Design and Synthesis of Pinanamine Derivatives as Anti-Influenza A M2 Ion Channel Inhibitors.
Nelson M, Detmer SE, Wentworth DE, Tan Y, et al.
Genomic reassortment of influenza A virus in North American swine, 1998-2011.
Duan M, Li WC, Vlahos R, Maxwell MJ, et al.
Distinct macrophage subpopulations characterize acute infection and chronic inflammatory lung disease.
Cho JH, Kim CD, Kim MS, Kang ES, et al.
The impact of A(H1N1)pdm09 infection on renal transplant recipients: a multicenter cohort study.
Tang JW, Loh TP, Lee CK, Lee HK, et al.
Lack of oseltamivir-resistance in A/H1N1p-infected patients, Singapore.
Thompson MG, Breiman RF, Hamel MJ, Desai M, et al.
Influenza and malaria co-infection among young children in western Kenya, 2009-2011.
Schlaudecker EP, McNeal MM, Dodd CN, Ranz JB, et al.
Pregnancy Influences the Antibody Response to Trivalent Influenza Immunization.
Ayllon J, Russell RJ, Garcia-Sastre A, Hale BG, et al.
Contribution of NS1 effector domain dimerization to influenza A virus replication and virulence.
Lu X, Shi Y, Gao F, Xiao H, et al.
Insights into avian influenza virus pathogenicity: the hemagglutinin precursor HA0 of H16 subtype has an alpha-helix structure in its cleavage site with an inefficient HA1/HA2 cleavage.
Cho CH, Woo MK, Kim JY, Cheong S, et al.
Evaluation of five rapid diagnostic kits for influenza A/B virus.
Chan KH, Chan KM, Ho YL, Lam YP, et al.
Quantitative analysis of four rapid antigen assays for detection of pandemic H1N1 2009 compared with seasonal H1N1 and H3N2 influenza A viruses on nasopharyngeal aspirates from patients with influenza.
Lagler H, Tobudic S, Ramharter M, Elandt K, et al.
Pandemic whole-virion, Vero-cell-derived, adjuvant-free influenza A H1N1 vaccine in patients with solid tumors and hematologic malignancies receiving concurrent anticancer treatment: Immunogenicity, tolerability, and acceptability during the pandemic
Das SC, Hatta M, Wilker PR, Myc A, et al.
Nanoemulsion W(80)5EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine.
Hughes B, Hayden F, Perikov Y, Hombach J, et al.
Report of the 5th meeting on influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organization, Geneva, 16-17 November 2011.
Chen WH, Winokur PL, Edwards KM, Jackson LA, et al.
Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.
Goni N, Moratorio G, Coppola L, Ramas V, et al.
BAYESIAN COALESCENT ANALYSIS OF PANDEMIC H1N1 INFLUENZA A VIRUS CIRCULATING IN THE SOUTH AMERICAN REGION.
-
------
Research Articles Abstracts?September 27 2012 Issue
Research Articles Abstracts?September 27 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?September 27 2012 Issue Abstracts List
Shafar S.
Vaccination for voluntary and private sector workers should be free.
Cox CM, D'Mello T, Perez A, Reingold A, et al.
Increase in Rates of Hospitalization Due to Laboratory-Confirmed Influenza Among Children and Adults During the 2009-10 Influenza Pandemic.
Lin Y, Zhao YB, Zeng XJ, Lu CP, et al.
Complete Genome Sequence of an H3N2 Canine Influenza Virus from Dogs in Jiangsu, China.
Liu G, Song L, Reiserova L, Trivedi U, et al.
Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.
Ambrose CS, Wu X, Jones T, Mallory RM, et al.
The role of nasal IgA in children vaccinated with live attenuated influenza vaccine.
Uchida Y, Suzuki Y, Shirakura M, Kawaguchi A, et al.
Genetics and infectivity of H5N1 highly pathogenic avian influenza viruses isolated from chickens and wild birds in Japan during 2010-11.
-
------
Research Articles Abstracts ? October 5 2012 Issue
Research Articles Abstracts ? October 5 2012 Issue
[Source: AMEDEO Influenza, homepage (
LINK ).
Research Articles Abstracts ? October 5 2012 Issue Abstracts List
YAMADA H, Moriishi E, Haredy AM, Takenaka N, et al.
Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains.
LEE SM, Yen HL.
Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection.
CHO HG, Choi JH, Kim WH, Hong HK, et al.
High prevalence of amantadine-resistant influenza A virus isolated in Gyeonggi Province, South Korea, during 2005-2010.
HAWKES N.
Too few school nurses to administer proposed flu vaccination programme, experts say.
KANG HM, Choi JG, Kim KI, Park HY, et al.
Genetic and antigenic characteristics of H4 subtype avian influenza viruses in Korea and their pathogenicity in quails, domestic ducks and mice.
HAYNES L, Szaba FM, Eaton SM, Kummer LW, et al.
Immunity to the Conserved Influenza Nucleoprotein Reduces Susceptibility to Secondary Bacterial Infections.
VERHELST J, Parthoens E, Schepens B, Fiers W, et al.
Interferon-inducible Mx1 protein inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly.
POWELL TJ, Silk JD, Sharps J, Fodor E, et al.
Pseudotyped Influenza A Virus as a Vaccine for the induction of Heterotypic Immunity.
ZHU X, McBride R, Nycholat CM, Yu W, et al.
Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic acid receptors.
LIU J, Zhang S, Tan S, Yi Y, et al.
Cross-allele CTL responses against 2009 pandemic H1N1 influenza A virus among HLA-A24 and HLA-A3 supertype-positive individuals.
TAKASHITA E, Muraki Y, Sugawara K, Asao H, et al.
Intrinsic Temperature Sensitivity of Influenza C Virus Hemagglutinin-Esterase-Fusion Protein.
?
Influenza A (H3N2) Variant Virus-Related Hospitalizations - Ohio, 2012. ?
Influenza vaccination coverage among pregnant women - 2011-12 influenza season, United States.
?
Influenza vaccination coverage among health-care personnel - 2011-12 influenza season, United States.
LEE PS, Yoshida R, Ekiert DC, Sakai N, et al.
Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity.
PASCUA PN, Song MS, Lee JH, Baek YH, et al.
Virulence and transmissibility of H1N2 influenza virus in ferrets imply the continuing threat of triple-reassortant swine viruses.
ZHU X, Yang H, Guo Z, Yu W, et al.
Crystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active site.
WELCH BD, Liu Y, Kors CA, Leser GP, et al.
Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 fusion protein.
LI Q, Sun X, Li Z, Liu Y, et al.
Structural and functional characterization of neuraminidase-like molecule N10 derived from bat influenza A virus.
ORTIZ JR, Neuzil KM, Ahonkhai VI, Gellin BG, et al.
Translating vaccine policy into action: A report from the Bill&Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings.
ISAI A, Durand J, Le Meur S, Hidalgo-Simon A, et al.
Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review.
BEATO MS, Mancin M, Bertoli E, Buratin A, et al.
Infectivity of H7 LP and HP influenza viruses at different temperatures and pH and persistence of H7 HP virus in poultry meat at refrigeration temperature.
LV J, Wei B, Yang Y, Yao M, et al.
Experimental transmission in guinea pigs of H9N2 avian influenza viruses from indoor air of chicken houses.
SMEE DF, von Itzstein M, Bhatt B, Tarbet EB, et al.
Exacerbation of Influenza Virus Infections in Mice by Intranasal Treatments and Implications for Evaluation of Antiviral Drugs.
We have screened the following journals for you:
Am J Med
Ann Intern Med
Antimicrob Agents Chemother
Antiviral Res
Arch Intern Med
Arch Virol
Biochem Biophys Res Commun
Biochem Soc Trans
Biochemistry
BMJ
Cell
Clin Diagn Lab Immunol
Commun Dis Rep CDR Wkly
Drug Saf
Drugs
Epidemiol Infect
Eur J Epidemiol
J Clin Microbiol
J Epidemiol Community Health
J Exp Med
J Gen Virol
J Immunol
J Infect
J Infect Dis
J Virol
J Virol Methods
JAMA
Lancet
MMWR Morb Mortal Wkly Rep
N Engl J Med
Pediatrics
Proc Natl Acad Sci U S A
Vaccine
Virology
Virus Res
-
--------
